Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Xu

Showing results (71-80 of 154) with videos related to

Pageof 16
Sort By:
Zhonghua Nei Ke Za Zhi|January 12, 2018
[Outcomes of alternative donor allogeneic hematopoietic stem cell transplantation for Fanconi anemia: a five cases report]W J Wang, Y Q Sun, F F Tang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 26, 2019
[Effects of chemotherapy combined with donor lymphocyte infusion on chronic graft-versus-host disease and prognosis in minimal residual disease positive patients after allogeneic hematopoietic stem cell transplantation]Y X Shi, X H Zhang, L P Xu, et al.
Bone Marrow Transplantation|October 24, 2017
Correlation between pediatric donor characteristics and cell compositions in mixture allografts of combined G-CSF-mobilized PBSCs and bone marrow allograftsL-Q Cao, L Liu, L-P Xu, et al.
Bone Marrow Transplantation|December 9, 2014
Presence of CD34(+)CD38(-)CD58(-) leukemia-propagating cells at diagnosis identifies patients at high risk of relapse with Ph chromosome-positive ALL after allo-hematopoietic SCTY Kong, L-P Xu, Y-R Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 22, 2023
[Treatment responses, outcomes, and prognostic factors associated with them in patients with secondary acute myeloid leukemia]L Ma, T Zhao, Y Y Chen, et al.
Zhonghua Nei Ke Za Zhi|August 3, 2022
[Application value of metagenomic next-generation sequencing for infectious pathogens in patients receiving allogeneic hematopoietic stem cell transplantation]J H Sun, X H Zhang, X D Mo, et al.
Zhonghua Nei Ke Za Zhi|September 22, 2021
[Prognostic significance of DEK-NUP214 fusion gene in patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation]M G Gao, Q Fu, Y Z Qin, et al.
Transplantation Proceedings|June 23, 2011
Basiliximab for the treatment of steroid-refractory acute graft-versus-host disease after unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantationJ Z Wang, K Y Liu, L P Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 16, 2026
[Efficacy and safety of basiliximab in gastrointestinal chronic graft-versus-host disease]X L Zhu, J Z Wang, H X Fu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 17, 2021
[BK virus encephalitis in children with hematopoietic stem cell transplantation]N Li, X J Huang, Y Wang, et al.
Pageof 16

Showing results (71-80 of 154) with videos related to

Sort By:
Pageof 16
Zhonghua Nei Ke Za Zhi|January 12, 2018
[Outcomes of alternative donor allogeneic hematopoietic stem cell transplantation for Fanconi anemia: a five cases report]W J Wang, Y Q Sun, F F Tang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 26, 2019
[Effects of chemotherapy combined with donor lymphocyte infusion on chronic graft-versus-host disease and prognosis in minimal residual disease positive patients after allogeneic hematopoietic stem cell transplantation]Y X Shi, X H Zhang, L P Xu, et al.
Bone Marrow Transplantation|October 24, 2017
Correlation between pediatric donor characteristics and cell compositions in mixture allografts of combined G-CSF-mobilized PBSCs and bone marrow allograftsL-Q Cao, L Liu, L-P Xu, et al.
Bone Marrow Transplantation|December 9, 2014
Presence of CD34(+)CD38(-)CD58(-) leukemia-propagating cells at diagnosis identifies patients at high risk of relapse with Ph chromosome-positive ALL after allo-hematopoietic SCTY Kong, L-P Xu, Y-R Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 22, 2023
[Treatment responses, outcomes, and prognostic factors associated with them in patients with secondary acute myeloid leukemia]L Ma, T Zhao, Y Y Chen, et al.
Zhonghua Nei Ke Za Zhi|August 3, 2022
[Application value of metagenomic next-generation sequencing for infectious pathogens in patients receiving allogeneic hematopoietic stem cell transplantation]J H Sun, X H Zhang, X D Mo, et al.
Zhonghua Nei Ke Za Zhi|September 22, 2021
[Prognostic significance of DEK-NUP214 fusion gene in patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation]M G Gao, Q Fu, Y Z Qin, et al.
Transplantation Proceedings|June 23, 2011
Basiliximab for the treatment of steroid-refractory acute graft-versus-host disease after unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantationJ Z Wang, K Y Liu, L P Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 16, 2026
[Efficacy and safety of basiliximab in gastrointestinal chronic graft-versus-host disease]X L Zhu, J Z Wang, H X Fu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 17, 2021
[BK virus encephalitis in children with hematopoietic stem cell transplantation]N Li, X J Huang, Y Wang, et al.
Pageof 16